These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13083870)

  • 1. [Estrogen depot injections in therapy of carcinoma of the prostate].
    FRANCESE A
    Gazz Med Ital; 1953 May; 112(5):138-41. PubMed ID: 13083870
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-resectable carcinoma of the prostate rendered resectable by endocrine therapy.
    Chute R; Fox BM
    J Urol; 1966 Apr; 95(4):577-9. PubMed ID: 5931205
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukaemia and oestrogen therapy.
    STANLEY DA
    Br Med J; 1957 Jun; 1(5033):1460. PubMed ID: 13436822
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer of the prostate:estrogen therapy: natural conjugated estrogen vs. Stillbestrol: A point of view.
    Kaplan L
    Rev Surg; 1968; 25(5):323-9. PubMed ID: 4301296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Revaluation of estrogen therapy on prostate cancer].
    Takezawa Y; Kobayashi M; Yamanaka H
    Nihon Rinsho; 2000 Jul; 58 Suppl():223-7. PubMed ID: 11022718
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of estrogen therapy on metastatic carcinoma of the prostate.
    Anikwe RM
    Int Surg; 1977 Oct; 62(10):532-6. PubMed ID: 591215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resorption and effectiveness of implanted compressed hormones in carcinoma of the prostate].
    Ziesche HW
    Urol Int; 1965; 20(5):289-304. PubMed ID: 5863979
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen therapy in carcinoma of the prostate.
    BIRKE G; FRANKSSON C; PLANTIN LO
    Acta Chir Scand; 1955 Apr; 109(1):1-10. PubMed ID: 14387447
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoma of the prostate.
    RICHES EW
    Br J Clin Pract; 1956 Nov; 10(11):729; passim. PubMed ID: 13374182
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience in treating metastic carcinoma of prostate with honvan (''ST 52-ASTA'')].
    ROCKSTROH H
    Z Urol; 1955; 48(11):720-30. PubMed ID: 13300707
    [No Abstract]   [Full Text] [Related]  

  • 12. Planned cytostatic therapy of carcinoma of the prostate.
    WARNECKE CE
    Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of conservative therapy in prostate carcinoma].
    PAGEL W
    Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine inhibition as related to carcinoma of the prostate.
    VALK WL; OWENS RH
    J Urol; 1954 Sep; 72(3):516-24. PubMed ID: 13202240
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate].
    Hayashi T; Takenawa J; Ryoji O; Hiura M; Taki Y; Kiriyama T
    Hinyokika Kiyo; 1989 May; 35(5):807-13. PubMed ID: 2478002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal treatments of prostate cancer].
    Kuhn JM
    Rev Prat; 1990 Nov; 40(25):2357-62. PubMed ID: 2124721
    [No Abstract]   [Full Text] [Related]  

  • 17. The choice of estrogen preparations in the treatment of prostatic cancer.
    Morales A; Pujari B
    Can Med Assoc J; 1975 Nov; 113(9):865-7. PubMed ID: 1182631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone therapy in carcinoma of the prostate].
    Marberger H
    Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
    [No Abstract]   [Full Text] [Related]  

  • 19. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS; Pitts WR
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens.
    Band PR; Banerjee TK; Patwardhan VC; Eid TC
    Can Med Assoc J; 1973 Oct; 109(8):697-9. PubMed ID: 4746128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.